WenZhi Yang

Dr. WenZhi Yang


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
HLHaiying Li
Haiying Li
YXYuhan Xue
Yuhan Xue
BJBei Jia
Bei Jia
YBYun Bai
Yun Bai
YZYueyue Zuo
Yueyue Zuo
HTHong-Bo Tang
Hong-Bo Tang

1 June 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
YDYumeng Duan
Yumeng Duan
KLKaiyue Li
Kaiyue Li
HWHuangwei Wang
Huangwei Wang
TWTong Wu
Tong Wu
YZYafei Zhao
Yafei Zhao
WYWenZhi Yang
WenZhi Yang

1 January 2014 in Carbohydrate Polymers
Verified
Journal Article
Closed access
WYWenZhi Yang
WenZhi Yang
MWMiaomiao Wang
Miaomiao Wang
LMLilan Ma
Lilan Ma
HLHaiying Li
Haiying Li
LHLe Huang
Le Huang

1 August 2016 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
WYWenZhi Yang
WenZhi Yang
HLHaiying Li
Haiying Li
TPTingting Pan
Tingting Pan
YCYing Cui
Ying Cui
XLXiaxia Li
Xiaxia Li
SSShigang Shen
Shigang Shen
The objective of this work was to prepare an oil/water glimepiride (GM) microemulsion (ME) for oral administration to improve its solubility and enhance its bioavailability. Based on a solubility study, pseudoternary phase diagrams, and Box–Behnken design, the oil/water GMME formulation was optimized and prepared. GMME was characterized by dynamic laser light scattering, zeta potential, transmission electron microscopy, and viscosity. The in vitro drug release, storage stability, pharmacodynamics, and pharmacokinetics of GMME were investigated. The optimized GMME was composed of Capryol 90 (oil), ­Cremophor RH40 (surfactant), and Transcutol (cosurfactant), and increased GM solubility up to 544.6±4.91 µg/mL. The GMME was spherical in shape. The particle size and its polydispersity index were 38.9±17.46 nm and 0.266±0.057, respectively. Meanwhile, the GMME was physicochemically stable at 4°C for at least 3 months. The short-term efficacy in diabetic mice provided the proof that blood glucose had a consistent and significant reduction at a dose of 375 µg/kg whether via IP injection or IG administration of GMME. Compared with the glimepiride suspensions or glimepiride-meglumine complex solution, the pharmacokinetics of GMME in Wistar rats via IG administration exhibited higher plasma drug concentration, larger area under the curve, and more enhanced oral bioavailability. There was a good correlation of GMME between the in vitro release values and the in vivo oral absorption. ME could be an effective oral drug delivery system to improve bioavailability of GM.

1 March 2017 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
MCMing-Mao Chen
Ming-Mao Chen
HCHuan Cao
Huan Cao
YLYuan-Yuan Liu
Yuan-Yuan Liu
YLYan Liu
Yan Liu
FSFei-Fei Song
Fei-Fei Song
WYWenZhi Yang
WenZhi Yang

1 September 2015 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
HLHaiying Li
Haiying Li
LMLilan Ma
Lilan Ma
XLXiaxia Li
Xiaxia Li
XCXin Cui
Xin Cui
WYWenZhi Yang
WenZhi Yang
MCMingmao Chen
Mingmao Chen